Clinical Trials Logo
  1. Home
  2. Post-Traumatic Stress Disorder
  3. NCT06303648
  4. Details
NCT06303648 Clinical Trial

A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects

Post Traumatic Stress Disorder Clinical Trial

Official title:
A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT06303648
Other study ID # TSND201-PK-101
Secondary ID
Status Recruiting
Phase Phase 1
First received
Last updated
Start date March 20, 2024
Est. completion date May 11, 2024

Study information
Verified date April 2024
Source Transcend Therapeutics
Contact Ashley Lauritsch
Phone +1 (952) 250-7788
Email ashley@transcendtherapeutics.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is an open-label, single, ascending dose study evaluating the PK and safety of methylone in healthy subjects.

Recruitment information / eligibility
Status Recruiting
Enrollment 24
Est. completion date May 11, 2024
Est. primary completion date May 4, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 25 Years to 55 Years
Eligibility Key Inclusion Criteria: - Healthy adult male or female aged 25 to 55 inclusive - Normal resting ECG - Normal hematologic and hepatic function - Normal renal function Key Exclusion Criteria: - Vital sign abnormalities - Positive urine drug screen at screening and / or Day -1 - Current mental illness such as depression, anxiety disorder, schizophrenia or other psychotic disorders

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Methylone
Oral dose of methylone

Locations
Country Name City State
Australia CMAX Clinical Research Adelaide South Australia

Sponsors (1)
Lead Sponsor Collaborator
Transcend Therapeutics

Country where clinical trial is conducted

Australia, 

Outcome
Type Measure Description Time frame Safety issue
Primary Cmax: Maximum Observed Plasma Concentration for methylone 48 hours following the dose
Primary AUC: Area under the plasma concentration-time curve for methylone 48 hours following the dose
Secondary Incidence and frequency of adverse events 10 days after the dose
Secondary Change overtime in Visual Analog Scales 12 hours after the dose
See also
  Status Clinical Trial Phase
Recruiting NCT05915013 - Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response Phase 1
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Recruiting NCT05934175 - Intensive Treatment Versus Standard Weekly Prolonged Exposure for Adults With Post-Traumatic Stress Disorder N/A
Recruiting NCT05934162 - Efficacy of Internet-delivered Cognitive-behavior Therapy for PTSD N/A
Completed NCT04460014 - Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT N/A
Recruiting NCT05877807 - Effect of Baclofen to Prevent Post-Traumatic Stress Disorder
Active, not recruiting NCT05992649 - The Effect of Aquatic Physiotherapy on Veterans Suffering From PTSD - a 40-week Pilotproject N/A
Terminated NCT04404712 - FAAH Availability in Psychiatric Disorders: A PET Study Early Phase 1
Not yet recruiting NCT05331534 - Effect of Attentional Therapy on Post-traumatic Stress Disorder N/A
Not yet recruiting NCT03649607 - Accelerated Resolution Therapy for HIV Positive African, Caribbean and Black N/A
Not yet recruiting NCT04076215 - Biochemical and Physiological Response to Stressogenic Stimuli N/A
Not yet recruiting NCT02545192 - A Pilot Study of Low Field Magnetic Stimulation in PTSD: Three Daily Treatments Phase 1
Completed NCT02329418 - Written Document to Assist Family During Decision of Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit N/A
Active, not recruiting NCT00978484 - A Head-to-head Comparison of Virtual Reality Treatment for Post Traumatic Stress Disorder Phase 3
Completed NCT00760734 - Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD) Phase 1
Completed NCT03278171 - Early Detection of Patients at Risk of Developing a Post-traumatic Stress Disorder After a Stay in Intensive Care Unit
Recruiting NCT05874362 - People Bereaved by Violent Death : Negative Event Biases and Temporal Perception N/A
Terminated NCT03898843 - Assisted Animal Therapy: ReAnimal N/A
Recruiting NCT04747379 - Psychological Effect of Explicit Recall After Sedation (PEERS)
Completed NCT03248167 - Cannabidiol as a Treatment for AUD Comorbid With PTSD Phase 1/Phase 2